Aliskiren labels and packages

Revision as of 15:18, 25 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Aliskiren}} {{CMG}}; {{AE}} {{SS}} ==Labels and Packages== {| |thumb|800px |} {| |thumb|800px |} <ref name="dai...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Aliskiren
TEKTURNA® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Aliskiren
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Labels and Packages


[1]

References

  1. ↑ "TEKTURNA (ALISKIREN HEMIFUMARATE) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION]". Retrieved 25 February 2014.

Template:Agents acting on the renin-angiotensin system

Retrieved from "https://www.wikidoc.org/index.php?title=Aliskiren_labels_and_packages&oldid=947493"